Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v4-FR
Language French French
Date Updated 2022-12-05 2022-12-05
Drug Identification Number 02395150 02395150
Brand name 0.9% SODIUM CHLORIDE INJECTION 0.9% SODIUM CHLORIDE INJECTION
Common or Proper name 0.9% SODIUM CHLORIDE INJECTION 0.9% SODIUM CHLORIDE INJECTION
Company Name FRESENIUS KABI CANADA LTD FRESENIUS KABI CANADA LTD
Ingredients SODIUM CHLORIDE SODIUM CHLORIDE
Strength(s) 900MG 900MG
Dosage form(s) SOLUTION SOLUTION SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 1000mL 1000mL
ATC code B05XA B05XA
ATC description I.V. SOLUTION ADDITIVES I.V. SOLUTION ADDITIVES
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2022-10-01 2022-10-01
Estimated end date Unknown Unknown
Actual end date 2022-11-30 2022-11-30
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments Fresenius Kabi Canada regrets to advise that due to increased demand, our Sodium Chloride 0.9% Injection freeflex® Bag 1000 mL will be placed on allocation effective October 1, 2022. Customers will be allocated 200% of historical monthly demand. Fresenius Kabi Canada regrets to advise that due to increased demand, our Sodium Chloride 0.9% Injection freeflex® Bag 1000 mL will be placed on allocation effective October 1, 2022. Customers will be allocated 200% of historical monthly demand.
Health Canada comments